Examen clinique et paraclinique d’une neuropathie optique non traumatique de l’adulte

Bidot, 2012, Neuropathies optiques, EMC – Traité Med AKOS, 7, 1, 10.1016/S1634-6939(12)58713-2 Biousse, 2016, Diagnosis and clinical features of common optic neuropathies, Lancet Neurol, 15, 1355, 10.1016/S1474-4422(16)30237-X The optic Neuritis Study Groupe, 1991, The clinical profile of optic neuritis: experience of the optic neuritis treatment trial, Arch Ophthalmol, 109, 1673, 10.1001/archopht.1991.01080120057025 Toanen, 2016, Neuropathies optiques inflammatoires, EMC – Ophtalmol, 14, 1 Selhorst, 1995, Uhthoff and his symptom, J Neuroophthalmol, 15, 63, 10.1097/00041327-199512000-00047 Opara, 2016, Uhthoff‘s phenomenon 125 years later – what do we know today?, J Med Life, 9, 101 Swerdloff, 1981, Movement phosphenes in optic neuritis, J Clin Neuroophthalmol, 1, 279 Arndt, 2012 Piro, 2019, Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease, Int Ophthalmol, 39, 671, 10.1007/s10792-018-0838-x Maynard, 2016, Mesopic Pelli–Robson contrast sensitivity and MP-1 microperimetry in healthy ageing and age-related macular degeneration, Acta Ophthalmol (Copenh), 94, e772, 10.1111/aos.13112 Darugar, 2019, Neuropathies optiques ischémiques, EMC, 10 Messerer, 2013, Intérêt de l’échographie du diamètre de l’enveloppe du nerf optique pour la détection non invasive de l’hypertension intracrânienne, Neurochirurgie, 59, 55, 10.1016/j.neuchi.2013.02.001 Laurent, 2021, Conduite à tenir devant une neuropathie optique : bilan pratique clinique, Ophtalmologie Le Page, 2015, Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, Lancet, 386, 974, 10.1016/S0140-6736(15)61137-0 Poujade, 2016, Amélioration rapide de la fonction visuelle après corticothérapie orale à forte dose chez des patients atteints de neuropathie optique inflammatoire, J Fr Ophtalmol, 39, 691, 10.1016/j.jfo.2016.03.008 Bonnan, 2018, Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders, J Neurol Neurosurg Psychiatry, 89, 346, 10.1136/jnnp-2017-316286